InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Browse the complete record of transactions filed by Nandabalan Krishnan, Director. Director active across 1 companies, notably BioXcel Therapeutics, Inc.. Cumulatively, 2 disclosures have been recorded. Total volume traded: €24.5m. The latest transaction was filed on 25 June 2021 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
€12m473,250 shares@ €25.8403100.0% of flow
Common Stock
SEC:0001104659-21-086946·
€12m473,250 shares@ €25.840339.62% mcap50.0% of flow
Common Stock
SEC:0001104659-21-086946:0·
2 of 2 declarations
About Nandabalan Krishnan
Krishnan Nandabalan is a Board Member of BioXcel Therapeutics, Inc. He brings expertise in corporate strategy and governance. His role on the board allows him to actively participate in strategic decision-making for the company. Through his experience, he helps guide growth initiatives and strengthen BioXcel's market position.
